KalVista Pharmaceuticals' Series B Round

KalVista Pharmaceuticals raised a round of funding on July 22, 2015.

KalVista Pharmaceuticals (NASDAQ: KALV) is a research-led pharmaceutical company focused on the discovery, development, and commercialization of small molecule serine protease inhibitors as new treatm…

Articles about KalVista Pharmaceuticals' Series B Round: